These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33067115)

  • 21. Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis.
    Gebremariam T; Wiederhold NP; Alqarihi A; Uppuluri P; Azie N; Edwards JE; Ibrahim AS
    J Antimicrob Chemother; 2017 Feb; 72(2):462-466. PubMed ID: 27798213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucormycosis: New Developments into a Persistently Devastating Infection.
    Danion F; Aguilar C; Catherinot E; Alanio A; DeWolf S; Lortholary O; Lanternier F
    Semin Respir Crit Care Med; 2015 Oct; 36(5):692-705. PubMed ID: 26398536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral mucormycosis in a diabetic man.
    Uy EM; Rustagi T; Khera S
    Conn Med; 2011 May; 75(5):273-9. PubMed ID: 21678839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially.
    Jiang N; Zhao G; Yang S; Lin J; Hu L; Che C; Wang Q; Xu Q
    BMC Ophthalmol; 2016 Jan; 16():10. PubMed ID: 26758904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucor cerebral abscess associated with intravenous drug abuse.
    Fong KM; Seneviratne EM; McCormack JG
    Aust N Z J Med; 1990 Feb; 20(1):74-7. PubMed ID: 2322206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infrequent presentations of mucormycosis in patients with myelodysplastic syndrome and acute leukemia: case series and review of literature.
    De Yao JT; Al-Ameri A; Garcia-Manero G; Quintás-Cardama A
    Clin Lymphoma Myeloma Leuk; 2011 Oct; 11(5):446-51. PubMed ID: 21820986
    [No Abstract]   [Full Text] [Related]  

  • 27. Economic impact of managing invasive mold disease with isavuconazole compared with liposomal amphotericin B followed by posaconazole in Spain.
    Moya-Alarcón C; Azanza JR; Barberán J; Ferrer R; Kwon M; Moreno A; Rubio-Terrés C; Gálvez-Santisteban M
    Expert Rev Anti Infect Ther; 2024 Aug; 22(8):713-720. PubMed ID: 38494912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral mucormycosis associated with intravenous drug use: three case reports and review.
    Hopkins RJ; Rothman M; Fiore A; Goldblum SE
    Clin Infect Dis; 1994 Dec; 19(6):1133-7. PubMed ID: 7888545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Mucorales DNA load in cerebrospinal fluid in a patient with possible cerebral mucormycosis treated with intravenous liposomal amphotericin B.
    Shigemura T; Nakazawa Y; Matsuda K; Motobayashi M; Saito S; Koike K
    Int J Infect Dis; 2014 Dec; 29():200-2. PubMed ID: 25461663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isavuconazonium sulfate: a new agent for the treatment of invasive aspergillosis and invasive mucormycosis.
    Kovanda LL; Maher R; Hope WW
    Expert Rev Clin Pharmacol; 2016 Jul; 9(7):887-97. PubMed ID: 27160418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 51-Year-Old Woman With a Mediastinal Mass.
    Coomes DS; Logan RL; Backous CA; Adeyemi OA
    Chest; 2021 Mar; 159(3):e141-e145. PubMed ID: 33678281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of rhinocerebral mucormycosis by a combination of aggressive surgical debridement and the use of systemic liposomal amphotericin B and local therapy with nebulized amphotericin--a case report.
    Raj P; Vella EJ; Bickerton RC
    J Laryngol Otol; 1998 Apr; 112(4):367-70. PubMed ID: 9659500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden.
    Floros L; Kuessner D; Posthumus J; Bagshaw E; Sjölin J
    BMC Infect Dis; 2019 Feb; 19(1):134. PubMed ID: 30744563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrobulbar Injection of Amphotericin B for Orbital Mucormycosis.
    Hirabayashi KE; Kalin-Hajdu E; Brodie FL; Kersten RC; Russell MS; Vagefi MR
    Ophthalmic Plast Reconstr Surg; 2017; 33(4):e94-e97. PubMed ID: 27768642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Non-fatal disseminated mucormycosis in a solid organ transplant].
    Minet C; Bonadona A; Tabah A; Karkas A; Mescam L; Schwebel C; Hamidfar R; Pison C; Saint-Raymond C; Faure O; Salameire D; Timsit JF
    Rev Mal Respir; 2009 Nov; 26(9):998-1002. PubMed ID: 19953048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment Failure of Isavuconazole in a Patient with Cryptococcosis.
    Linder KA; Gandhi TN; Miceli MH
    Mycopathologia; 2019 Oct; 184(5):667-670. PubMed ID: 31451965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy.
    Jenks JD; Salzer HJ; Prattes J; Krause R; Buchheidt D; Hoenigl M
    Drug Des Devel Ther; 2018; 12():1033-1044. PubMed ID: 29750016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Affinity of Mucormycosis for Basal Ganglia in Intravenous Drug Users: Case Illustration and Review of Literature.
    Hazama A; Galgano M; Fullmer J; Hall W; Chin L
    World Neurosurg; 2017 Feb; 98():872.e1-872.e3. PubMed ID: 27923750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Encephalitis of the basal ganglia in an injection drug user.
    Carpenter M; Polk C; Castellani R; Mochoruk K; Sanche S; Stern B; Donnenberg MS
    Clin Infect Dis; 2007 Dec; 45(11):1479, 1522-4. PubMed ID: 17990237
    [No Abstract]   [Full Text] [Related]  

  • 40. Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent.
    Miceli MH; Kauffman CA
    Clin Infect Dis; 2015 Nov; 61(10):1558-65. PubMed ID: 26179012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.